Urinary clearance of 11‐nor‐9‐carboxy‐Δ9‐tetrahydrocannabinol: A detailed pharmacokinetic analysis
- 1 April 2022
- journal article
- research article
- Published by Wiley in Drug Testing and Analysis
- Vol. 14 (8) , 1368-1376
Abstract
Urine is a common matrix for screening for cannabis use. Urine assays typically measure total 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (THCCOOH) concentrations after hydrolysis cleaves the glucuronide. Urine THCCOOH concentration is adjusted by urine creatinine concentration or specific gravity, to account for variable hydration states. Therefore, we performed a population pharmacokinetic analysis of the urinary THCCOOH excretion, urinary flow rate, and creatinine excretion rate data. Urine was obtained over 168 h from six subjects who smoked low- (15.8 mg) and high-dose (33.8 mg) Delta(9)-tetrahydrocannabinol (THC) cigarettes on two occasions. Samples were analyzed for THCCOOH concentration by gas chromatography-mass spectrometry (GC-MS) and volume, time, and creatinine concentration measured. A population pharmacokinetic model of the urinary clearance of THCCOOH was created from these data, and potential covariates of urine creatinine concentration and urine creatinine excretion rate were assessed. Elimination clearance of THCCOOH was estimated as 0.104 +/- 0.088 L/min, and its urinary clearance was 0.0022 +/- 0.0015 L/min. Total urine excretion of THCCOOH was estimated at 2.3%. Urine flow rate and urine creatinine concentrations were significantly correlated, r(2) = 0.35. Creatinine excretion rate was 129.6 +/- 71.0 ml/min, and the intrasubject variability was 31%-52% (SD %) during the week. Urinary creatinine excretion rate was a significant covariate for the urinary clearance of THCCOOH. Creatinine clearance is a significant covariate for urinary THCCOOH clearance. Only 2%-3% of bioavailable THC is excreted as THCCOOH and THCCOO-glucuronide via the urine. Correction of urine drug and/or metabolite concentration with urine creatinine concentration or specific gravity may be more problematic than previously appreciated.Keywords
This publication has 16 references indexed in Scilit:
- Phase I and II Cannabinoid Disposition in Blood and Plasma of Occasional and Frequent Smokers Following Controlled Smoked CannabisClinical Chemistry, 2014
- Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometryClinica Chimica Acta, 2012
- The Pharmacokinetics and Bioavailability of Prochlorperazine Delivered as a Thermally Generated Aerosol in a Single Breath to VolunteersClinical Pharmacology & Therapeutics, 2008
- Effect of posture on creatinine clearance in late pregnancy and after pregnancy.Journal of Obstetrics and Gynaecology Research, 2007
- Diagnosing Model DiagnosticsClinical Pharmacology & Therapeutics, 2007
- Pharmacokinetics and Metabolism of the Plant Cannabinoids, Δ 9-Tetrahydrocannibinol, Cannabidiol and Cannabinol2005
- Comparison of Specific Gravity and Creatinine for Normalizing Urinary Reproductive Hormone ConcentrationsClinical Chemistry, 2004
- Urinary Excretion Profiles of 11-Nor-9-Carboxy- 9-Tetrahydrocannabinol in Humans after Single Smoked Doses of MarijuanaJournal of Analytical Toxicology, 1996
- Blood Cannabinoids. I. Absorption of THC and Formation of 11-OH-THC and THCCOOH During and After Smoking Marijuana*Journal of Analytical Toxicology, 1992
- Restrictions on Use of Creatinine Clearance for Measurement of Renal Functional ReserveNephron, 1989